China Tracker - Safety/Risk Model (Stage One) for Jiangbo Pharmaceuticals (JGBO)

 Jiangbo Pharmaceuticals
 Going Public
Market Segment:
Going Public: 2007-10-01Reverse Merger
 Auditor
Auditor: Marcum Bernstein & Pinchuk
Number of Auditors (since Jan 1, 2009): 4
Auditor Resignations (since Jan 1, 2009): none 
 Internal Controls
Internal Controls (Management): not effective
Internal Controls (Audit): not performed 
Senior Management Changes (since Jan 1, 2009): 0 
Number of CFOs (since Jan 1, 2009): 1 
CFO Resignations (since Jan 1, 2009): 1
Main Shareholder (Cao Wubo): Chairman 
Ownership Percentage: 38.76% 
 Analyst Coverage
Total Coverage: no coverage
 Indicators
New Shares / Dilution (TTM): 0.42 million2.78%
Short Interest (2010-06-30): 0.14 million1.44% 
Account Receivables (MRQ): $20.76 million0.00%
 Recent Events
Delinquent with SEC Filings: YES
Short Seller Attacks (Corporate Governance): YES
Detailed Fraud Allegations: YES
 
 Auditor History (since January 1, 2009)
2011-04-19Marcum Bernstein & PinchukAppointment (Merger)
2011-04-19Bernstein & PinchukResignation (Merger)
2011-03-30Bernstein & PinchukAppointment
2011-03-30Frazer FrostContract Expired
2010-01-01Frazer FrostAppointment (Merger)
2010-01-01Moore Stephens Wurth Frazer and TorbetResignation (Merger)
2008-02-25Moore Stephens Wurth Frazer and TorbetAppointment
2008-02-25Sherb & Co.Dismissal
 Senior Management Trail (since January 1, 2009)
2011-03-15Elsa SungCFOResignation
2007-10-01Elsa SungCFOAppointment
JGBO
Healthcare & Drugs
SAFETY/RISK SCORE
10%
EXTREME RISK
Detailed Score: 85.78125/780
Current Price:  n/a
F10k Day (2007-10-02): -100.00%$12.40
2009 Close: -100.00%$11.00
2010 Close: -100.00%$5.72
High (2012-06-26): -100.00%$0.17
Low (2012-10-18): -100.00%$0.06
Exchange: N/A
Market Capitalization: n/a
Total Shares: 15.66 mill
Float: n/a
Last Quarter: 2011-03-31
Revenue (MRQ): 18.11 mill
Net Income (MRQ): 2.30 mill
Op. Cash Flow (MRQ): 9.90 mill
all financial data provided without warranty